​

Candel Therapeutics (CADL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Candel Therapeutics Revenue Highlights

00

Candel Therapeutics Revenue by Period

Candel Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31--100.00%
2022-12-31$125.00K-
2021-12-31$125.00K-
2020-12-31$125.00K-
2019-12-31$125.00K-

Candel Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Candel Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$1.00M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$1.78M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$31.00K-
2022-09-30$31.00K-
2022-06-30$31.00K-
2022-03-31$31.00K-
2021-12-31$31.00K-
2021-09-30$31.00K-
2021-06-30$31.00K-
2021-03-31$31.00K-
2020-12-31$31.00K-
2020-09-30$31.00K-
2020-06-30$31.00K-
2020-03-31$31.00K-

Candel Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Candel Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CAPRCapricor Therapeutics$22.27M-
PRQRProQR Therapeutics$6.38M$4.48M
IMMPImmutep$3.51M$2.11M
GNLXGenelux$8.00K-
EDITEditas Medicine--
CADLCandel Therapeutics--
ALDXAldeyra Therapeutics--
CABACabaletta Bio--
KYTXKyverna Therapeutics--
CTNMContineum Therapeutics, Inc. Class A--
MREOMereo BioPharma Group--

CADL Revenue FAQ

What is Candel Therapeutics’s yearly revenue?

Candel Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. CADL's yearly revenue for 2022 was $125K, representing an increase of 0% compared to 2021.

What is Candel Therapeutics’s quarterly revenue?

Candel Therapeutics's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). CADL's quarterly revenue for Q4 2024 was $1M, a 100.00% increase from the previous quarter (Q3 2024), and a -43.69% decrease year-over-year (Q4 2023).

What is Candel Therapeutics’s revenue growth rate?

Candel Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.